7th Introductory Pharmacometric Training Course
Pharmacokinetics & Pharmacodynamics 
of Protein Therapeutics
- Concepts and Hands-On Modeling and Simulation -

Course Directors: 
Bernd Meibohm, University of Tennessee
Johan Gabrielsson, Swedish University of Agricultural Sciences

The 5-day course will introduce participants to basic principles in the pharmacokinetic and pharmacodynamic evaluation of novel protein therapeutics and provide opportunities for hands-on PK and PK/PD modeling and simulation examples relevant for protein drugs. Topics include target-mediated drug disposition, tissue and tumor penetration, interspecies scaling, first-in human dose selection, immunogenicity, model-based drug development, biosimilars, and drug-drug interactions. 

Location: University of Tennessee College of Pharmacy, Memphis, TN, USA

Time: April 3-7, 2017

Last updated: January 27, 2017
Participants of the 6th 'PKPD of Protein Therapeutics' pharmacometric training course 2016
Hand-on exercises and simulations will be performed individually and in small groups using multiple software tools (There is no prior modeling experience required!).

The course has been held annually since 2011 and has been attended by several hundred scientists from large and small pharma (including companies such as Abbvie, Amgen, Bayer, Biogen-Idec, Bristol-Myers, Boehringer, Janssen, Merck, Novartis, Novo Nordisk and Pfizer), academic institutions, and regulatory agencies from North America, Europe and Asia.
Testimonials from 2016 participants:

"Good course all around. Lots to digest and good ammunition to take back to project teams and management!"

"This course was really a good opportunity to learn PK-PD of proteins. I will definitely apply the concepts in my research and encourage my peers to attend the course."

"I was very impressed with the course. I was wishing I had attended long ago before I started any work with biologics. My projects would have gone a lot smoother had I had this knowledge earlier. Almost wished it was longer, though that would be difficult, because there was so much to learn!"